Interleukin-6 regulates pancreatic α-cell mass expansion
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Interleukin-6 (IL-6) is systemically elevated in obesity and is a predictive factor to develop type 2 diabetes. Pancreatic islet pathology in type 2 diabetes is characterized by reduced β-cell function and mass, an increased proportion of α-cells relative to β-cells, and α-cell dysfunction. Here we show that the α cell is a primary target of IL-6 actions. Beginning with investigating the tissue-specific expression pattern of the IL-6 receptor (IL-6R) in both mice and rats, we find the highest expression of the IL-6R in the endocrine pancreas, with highest expression on the α-cell. The islet IL-6R is functional, and IL-6 acutely regulates both pro-glucagon mRNA and glucagon secretion in mouse and human islets, with no acute effect on insulin secretion. Furthermore, IL-6 stimulates α-cell proliferation, prevents apoptosis due to metabolic stress, and regulates α-cell mass in vivo . Using IL-6 KO mice fed a high-fat diet, we find that IL-6 is necessary for high-fat diet-induced increased α-cell mass, an effect that occurs early in response to diet change. Further, after high-fat diet feeding, IL-6 KO mice without expansion of α-cell mass display decreased fasting glucagon levels. However, despite these α-cell effects, high-fat feeding of IL-6 KO mice results in increased fed glycemia due to impaired insulin secretion, with unchanged insulin sensitivity and similar body weights. Thus, we conclude that IL-6 is necessary for the expansion of pancreatic α-cell mass in response to high-fat diet feeding, and we suggest that this expansion may be needed for functional β-cell compensation to increased metabolic demand.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interleukin (IL)-6, which is both an adipokine and myokine,287 was shown to influence the pancreas by controlling the expression of pro-glucagon mRNA as well as glucagon secretion. It also increases α-cell proliferation and islet mass while protecting the pancreas from metabolic stress-induced apoptosis.288”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [288]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Self-citationLiver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,538 · cited 1×
“Upon IL-6 binding to its receptor, the IL-6R forms a complex with the signal transducing transmembrane glycoprotein, gp130, and signals are transduced via activation of STAT3 and ERK signaling, regulating downstream targets such as c-myc and bcl-2 (7, 13, 14).”
BackgroundInflammatory Cytokines and the Risk to Develop Type 2 Diabetes
Spranger, J., Kroke, A., Möhlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.812 · Cited by 1,493
Interleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213 · cited 2×
“IL-6 KO mice are known to become obese and glucose intolerant after 6–9 months of age due to lack of IL-6 central nervous system effects (10).”
BackgroundAdvances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Increased Number of Islet-Associated Macrophages in Type 2 Diabetes
Ehses, J. A., Perren, A., Eppler, E., Ribaux, P., Pospisilik, J. A., Maor-Cahn, R., Gueripel, X., Ellingsgaard, H., Schneider, M. K. J., Biollaz, G., et al. (2007) · Diabetes · doi:10.2337/db06-1650 · Cited by 783
Self-citation共やくエクイン・エストロゲン(Premarin)服用閉経婦人の血清エクイリン,エストロン,エストラジオール値
Whittaker, P. G., Morgan, M. R., Dean, P., Cameron, E., & Lind, T. (1980) · The Lancet · Cited by 724
IL-6 signal transduction and its physiological roles: the signal orchestration model
Kamimura, D., Ishihara, K., & Hirano, T. (2003) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-003-0012-2 · Cited by 673 · cited 5×
“Since gp130 is ubiquitously expressed, specificity of IL-6R signaling is mainly mediated by tissue specific IL-6R expression, and/or the local action of soluble IL-6Rs (7).”
BackgroundInfluentialEvidence that interleukin-6 is produced in human skeletal muscle during prolonged running
Ostrowski, K., Rohde, T., Zacho, M., Asp, S., & Pedersen, B. K. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.949bp.x · Cited by 673 · cited 2×
“Proc Natl Acad Sci USA 104(8):2861–2866.”
Background
Research works printed but not linked: 1
- Winzell MS, Ahren J, Renstrom E, Ahren B. Beta cell specific overexpression of glucagon receptors results in improved insulin secretion in response to glucose but impaired response to glucagon. Diabetologia. 2007;50:S28. [Google Scholar]
Cited by
Items 201–281 of 281
A genetic mouse model for progressive ablation and regeneration of insulin producing beta-cells
Shamsi, F., Parlato, R., Collombat, P., & Mansouri, A. (2014) · Cell Cycle · doi:10.4161/15384101.2014.952176 · Cited by 12
Acute administration of interleukin-6 does not increase secretion of glucagon-like peptide-1 in mice
Christiansen, C. B., Jepsen, S. L., Svendsen, B., Balk-Møller, E., Dahlby, T., Kuhre, R. E., Hartmann, B., Mandrup-Poulsen, T. R., Deacon, C. F., Albrechtsen, N. J. W., et al. (2018) · Physiological Reports · doi:10.14814/phy2.13788 · Cited by 13
“High expression of the IL-6 receptor in the endocrine pancreas, especially on alpha-cells, has been reported in both mice and rats (Ellingsgaard et al. 2008), but our data do not support that activation of this receptor impacts glucagon secretion, at least not in an acute manner in mice.”
BackgroundResultSkeletal Muscle as Endocrine Organ
Ma, M., Zhang, Z., Hai, B., & Zhang, Y. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-88361-3_22 · Cited by 12
Shinjo, T., Nakatsu, Y., Iwashita, M., Sano, T., Sakoda, H., Ishihara, H., Kushiyama, A., Fujishiro, M., Nishimura, F., & Asano, T. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0047-y · Cited by 11
Farid, A., El-Alfy, L., & Madbouly, N. A. (2023) · Biologia · doi:10.1007/s11756-023-01436-0 · Cited by 12
Dauriz, M., Trombetta, M., Boselli, L., Santi, L., Brangani, C., Pichiri, I., Bonora, E., & Bonadonna, R. C. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0807-z · Cited by 10
Glucagon-like peptide-1 receptor blockade impairs islet secretion and glucose metabolism in humans
Welch, A. A., Farahani, R. A., Egan, A. M., LAURENTI, M. C., ZEINI, M., Vella, M., Bailey, K. R., Cobelli, C., Man, C. D., Matveyenko, A. V., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci173495 · Cited by 9
Liu, T., Liang, R., Wang, L., Zou, J., Wang, G., Liu, N., Sun, P., Liu, Y., Ding, X., Lu, C., et al. (2020) · Pancreas · doi:10.1097/mpa.0000000000001552 · Cited by 9
Schuppelius, B., Schüler, R., Pivovarova‐Ramich, O., Hornemann, S., Busjahn, A., Machann, J., Kruse, M., Park, S. Q., Kabisch, S., Csanalosi, M., et al. (2024) · Nutrients · doi:10.3390/nu16223905 · Cited by 8
Taneera, J., Khalique, A., Mohammed, A. K., Mussa, B. M., Sulaiman, N. D., Abu‐Gharbieh, E., El‐Huneidi, W., & Saber-Ayad, M. M. (2024) · Cells · doi:10.3390/cells13080685 · Cited by 8
“However, other studies have failed to find any effect of IL6 on insulin secretion in β -cells under diabetic-like conditions [22], or have suggested that IL6 may indirectly affect insulin secretion by increasing GLP-1 expression in α -cells [16].”
BackgroundResultAdropin Is Expressed in Pancreatic Islet Cells and Reduces Glucagon Release in Diabetes Mellitus
Ali, I. I., D’Souza, C. M., Tariq, S., & Adeghate, E. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189824 · Cited by 7
Beta‐cell death and dysfunction drives hyperglycaemia in organ donors
Shapey, I. M., Summers, A., O’Sullivan, J., Fullwood, C., Hanley, N. A., Casey, J., Forbes, S., Rosenthal, M. J., Johnson, P., Choudhary, P., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15248 · Cited by 7
ErbB3 is required for hyperaminoacidemia-induced pancreatic α cell hyperplasia
Kang, Q., Jia, J., Dean, E. D., Yuan, H., Dai, C., Li, Z., Jiang, F., Zhang, X.-K., Powers, A. C., Chen, W., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107499 · Cited by 7
“Inter-estingly, interleukin 6 – STAT3 pathway has been reported to be necessary for high-fat diet – induced a cell mass expansion (52).”
BackgroundLitter expansion alters metabolic homeostasis in a sex specific manner
Kurup, K., Mann, S. N., Jackson, J. A., Matyi, S., Ranjo‐Bishop, M., Freeman, W. M., Stout, M. B., Richardson, A. G., & Unnikrishnan, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0237199 · Cited by 7
“For example, increased levels of IL-6 has been shown to be correlated to improved glucose homeostasis [40, 42].”
BackgroundElusive liver factor that causes pancreatic α cell hyperplasia: A review of literature
Yu, R., Zheng, Y., Lucas, M. B., & Tong, Y.-G. (2015) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v6.i4.131 · Cited by 7
Nielsen, S. S., Christensen, G. L., Holst, J. J., & Billestrup, N. (2016) · Endocrinology · doi:10.1210/en.2016-1163 · Cited by 7
IL-6 decodes sex and diet-dependent circadian and metabolic rhythms
González-Vila, A., Ibrahim-Alasoufi, A. M., Luengo-Mateos, M., Pardo-García, V., Diaz-López, A., Fernández-Rodríguez, B., POUTANEN, M. H., Ohlsson, C., Tena‐Sempere, M., Diéguez-González, C., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102171 · Cited by 6
“All analyses were conducted in male mice, in line with prior studies examining IL-6 function during fasting [44 e 47], and to minimize biological variability in this initial mechanistic assessment.”
Muscle-to-organ cross-talk mediated by interleukin 6 during exercise: a review
Rad, R. S., & Panahzadeh, F. (2023) · Sport Sciences for Health · doi:10.1007/s11332-023-01102-7 · Cited by 5
“Available evidence suggests that IL-6 has a positive impact on β-cell mass in living organisms by promoting β-cell proliferation and protecting against apoptosis caused by metabolic stress [87].”
Hidouri, S., Driss, T., Tagougui, S., Kammoun, N., Chtourou, H., & Hammouda, O. (2024) · Sensors · doi:10.3390/s24030909 · Cited by 6
“Additionally, during exercise, muscle fibers produced IL-6 [79], enhancing both (Gl) uptake and fat oxidation [80,81].”
BackgroundGlucose Homeostasis in Pre-diabetic NOD and Lymphocyte-Deficient NOD/SCID Mice During Gestation
Coulaud, J., Durant, S., & Homo‐Delarche, F. (2010) · The Review of Diabetic Studies · doi:10.1900/rds.2010.7.36 · Cited by 6
Trehalose Protects Islets of Langerhans in HFD-fed Obese Mice: A Morphometric Analysis
Arai, C., Miyata, M., Yoshizane, C., Koide, K., Mizote, A., Arai, N., Hanaya, T., Arai, S., & Fukuda, S. (2013) · Nippon Eiyo Shokuryo Gakkaishi · doi:10.4327/jsnfs.66.17 · Cited by 4
Chinese herb couple against diabetes: integrating network pharmacology and mechanism study
Li, J., Jia, N., Cui, M., Li, Y., Jiang, D., & Chu, X. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2314263 · Cited by 4
“Interestingly, animal experiments showed that TCM group reduced IL-6 secretion in rats and was able to reduce the risk of disease (Ellingsgaard et al., 2008).”
Koepke, J. P., Long, W., Barr, A., & Light, P. E. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102259 · Cited by 3
“Our previous investigation found increased islet GLP-1 expression in T2D, leading us to test the effect of the T2D-associated cytokines IL6 and SDF1 α on proglucagon processing [3,44 — 46 ,68 ,69 ].”
Specific and redundant roles of PKBα/AKT1 and PKBβ/AKT2 in human pancreatic islets
Dietrich, M., Zuellig, R. A., Spinas, G. A., Lehmann, R., Tschopp, O., & Nießen, M. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.08.008 · Cited by 3
Harnessing Immune Cells to Enhance β-Cell Mass in Type 1 Diabetes
Dirice, E., & Kulkarni, R. (2016) · Journal of Investigative Medicine · doi:10.1136/jim-d-15-00196 · Cited by 2
Association of the IL‐6R rs2228145 polymorphism with diabetic nephropathy: A case‐control study
Izakovicova, P., Slezáková, S., Deissová, T., Poskerová, H., Linhartová, P. B., Dušek, L., Kaňková, K., & Hollá, L. I. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70073 · Cited by 2
“Anti-in fl ammatory classical IL-6 signaling is mediated through membrane-bound IL-6R, whereas soluble IL-6R (sIL-6R) activates pro-in fl ammatory trans-signaling. sIL-6R can be generated either by mRNA alternative splicing 19 or ectodomain shedding of the membrane-bound IL-6R via members of a disintegrin and metallopro…”
InfluentialXu, S., Hayashi, Y., Takagishi, Y., Itoh, M., & Murata, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064415 · Cited by 2
Enteroviral infections are not associated with type 2 diabetes
Liu, H., Geravandi, S., Grasso, A. M., Sikdar, S., Pugliese, A., & Maedler, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1236574 · Cited by 2
Arslan, B., Beyaz, S., Gök, Ö., Erman, O., Özercan, İ. H., & Aslan, A. N. (2024) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-024-03231-w · Cited by 2
Pancreatic Glucagon-Like Peptide 1: What is known?
Fava, G. E. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000397 · Cited by 2
“It has been shown that IL-6 stimulates α-cell proliferation, inhibits α-cell apoptosis, and upregulates both proglucagon mRNA and glucagon secretion in both murine and human islets [63].”
BackgroundInfluentialGlucagon and the Glucagon-Like Peptides
Drucker, D. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00034-2 · Cited by 2
Skeletal Myoblast Cells Enhance the Function of Transplanted Islets in Diabetic Mice
Kado, T., Tomimaru, Y., Kobayashi, S., Harada, A., Sasaki, K., Iwagami, Y., Yamada, D., Noda, T., Takahashi, H., Kita, S., et al. (2024) · Journal of Diabetes Research · doi:10.1155/2024/5574968 · Cited by 2
“Moreover, IL-6 receptors are expressed in islets and regulate islet proliferation [35], and several reports have demonstrated that IL-6 activates JAK-STAT signaling in islets [36, 37].”
BackgroundTruchan, N. A., Sandhu, H. K., Fenske, R. J., Buchanan, R., Moeller, J. R., Reuter, A., Harrington, J., & Kimple, M. E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/670000 · Cited by 2
“The systemic inflammation coincident with the insulin resistance of obesity further promotes mitochondrial and ER stress in already stressed betacells by the secretion of pro-inflammatory cytokines from insulin-resistant, M1-polarized macrophages resident within the islet itself, ultimately attracting cytotoxic immune…”
BackgroundSpatial molecular imaging of the human type 2 diabetic isletPreprint
Kolar, G. R., Ross, D., Killingbeck, E. E., Samson, W. K., & Yosten, G. L. C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.04.519955 · Cited by 2
Glucagon in Islet and Metabolic Regulation
Sandoval, D. A., Tong, J., & Alessio, D. D. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch7 · Cited by 1
Biomarkers of Insulin Resistance
Cox‐York, K. A., & Pereira, R. I. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-25057-7_11 · Cited by 1
Analysis of the Relationship between Physical Activity and Type-II Diabetes Mellitus in China
Chen, Y. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v36i.6272 · Cited by 1
Ren, J., Wang, X., Nakao, T., Libby, P., & Shi, G. (2023) · Cardiology Discovery · doi:10.1097/cd9.0000000000000096 · Cited by 1
Fujita, M., Miyazawa, T., Uchida, K., Uchida, N., Haji, S., Yano, S., Iwahashi, N., Hatayama, T., Katsuhara, S., Nakamura, S., et al. (2023) · Endocrinology · doi:10.1210/endocr/bqad181 · Cited by 1
Aplicación de la Cardiotrofina en un modelo experimental de diabetes mellitus
Jiménez-González, M., Prósper, F., & Barajas, M. A. (2012) · Depósito Académico Digital Universidad de Navarra (University of Navarra)
Pancreatic Islet β-Cell Failure in Obesity
Morioka, T., & Kulkarni, R. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1607-5_11
Ji, Y., & de Lima, M. E. (2012) · Journal of Toxicology · doi:10.1155/2012/501438 · Cited by 1
The Beta Cell in Metabolic Syndrome
Zarrouki, B., Fontès, G., Semache, M., Amyot, J., & Poitout, V. (2013) · Springer eBooks · doi:10.1007/978-3-319-01008-3_5
The History of GLP-1 and the Debate Regarding Its Tissue-Specific Expression
Fava, G. E., & Wu, H. (2014)
Souza‐Mello, V., Frantz, E. D. C., Gregório, B. M., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2013) · Revista Contexto & Saúde · doi:10.21527/2176-7114.2010.19.81-86
“A expansão da massa de células alfa faz-se necessária devido à aumentada demanda metabólica imposta pela compensação de células beta nos estados de resistência à insulina (Ellingsgaard et al., 2008).”
Angelini, F., Orlandi, C., Fiore, P. D., Gatteschi, L., Guerra, M., Marzatico, F., Rapetti, M., & Speciani, A. F. (2010) · Basic and clinical dermatology · doi:10.3109/9781439802724.008
Bahrami, J. (2011) · TSpace (University of Toronto)
Novel Enteroendocrine Cell Receptors Regulating Incretin Secretion and Glucose Homeostasis
Flock, G. B. (2012) · TSpace (University of Toronto)
Earpina, S. (2013) · Louisiana State University · doi:10.31390/gradschool_theses.1770
“Exposure to the cytokines, TNF-α and IL-6 released by adipocytes due to inflammation can impair β-cell functionality (82, 83).”
Interleukin-6 and exercise; early evidence of a novel myokine
Mr., B. H. (2018) · ScholarWorks at University of Montana
Saha, B. B., Thu, K., & Wijayanta, A. T. (2018) · Evergreen · doi:10.5109/1957499
Leslie, K. A. (2019) · Figshare
(2009) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32832eb365
Pancreatic β-Cell Regeneration in TIF-IA Knockout Mice
Shamsi, F. (2014) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4696
Treatment Regimes in Diabetes and Their Impact on Biomarkers: Exercise, Inflammation, and Lipids
Magalhães, J. P., Hetherington‐Rauth, M., & Sardinha, L. B. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_3-1
Treatment Regimes in Diabetes and Their Impact on Biomarkers: Exercise, Inflammation, and Lipids
Magalhães, J. P., Hetherington‐Rauth, M., & Sardinha, L. B. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_3
The gut microbiota: A driver of Type 2 diabetes
Scheithauer, T. P. M. (2023) · doi:10.5463/thesis.82
Hepatic insulin-degrading enzyme regulation and its role on glucagon signaling
González-Casimiro, C. M. (2022) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/60284
Muskulatur: „peripheres mechanisch- und Signalstoff-gestütztes Zentrum der Gesundheit“
Laube, W. (2023) · Springer eBooks · doi:10.1007/978-3-662-67753-7_8
Khalique, A., Hamad, M. A., & Taneera, J. (2023) · Advances in Biomedical and Health Sciences · doi:10.4103/abhs.abhs_44_23
Glucagon in Islet and Metabolic Regulation
Campbell, J. E., & D’Alessio, D. A. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch8
Guo, T., Zhang, H., Luo, Y., Yang, X., Wang, L., & Zhang, G. (2024) · Clinical and investigative medicine · doi:10.3138/cim-2024-2744
Deshmukh, N., Kalshetti, M. S., Patil, M., Nandanwar, M., & Sangle, G. V. (2025) · Drug Research · doi:10.1055/a-2557-8927
“Circulating levels of IL-6 are increased in type 2 diabetes and high-fat diet feeding [50, 51], and IL-6 has been linked to the release of glucagon and GLP-1 [52], while selective SGLT2 inhibitors are known to stimulate the secretion of IL-6, glucagon, and GLP-1 [53].”
Body Kines and Organ Crosstalks: A Mini Review
Elnaggar, N. K., & Elnaggar, M. (2025) · International Journal of Diabetes and Endocrinology · doi:10.11648/j.ijde.20251002.13
CORRELATION OF MEDODHATU IN MODERN PHYSIOLOGY: A REVIEW
Admaja, P. (2025) · International Journal of Research in Ayurveda and Pharmacy · doi:10.7897/2277-4343.16257
Chen, X. (2025) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.91992
Escrig, A., & de Neurociències, U. A. D. B. I. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Fernández‐Gayol, O., & Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, D. F. I. D. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Schuppelius, B. (2025) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-48721
O’Reilly, L., Thai, L. M., Sue, N., Dhenni, R., Castro-Martinez, A., Munoz, M. A., Rogers, M. J., Phan, T. G., Schmitz‐Peiffer, C., Irvine, K. M., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06638-6
Low-grade chronic inflammation in obesity: biomarkers and clinical perspectives
Gómez, M. G. (2024) · UCrea (University of Cantabria)
The Role of Pancreatic Preproglucagon in Regulating Local Inflammation in Mice
Zalucha, E., Hutch, C. R., Bethea, M. M., Cook, T. M., Unadkat, A., Wells, K. L., Kim, K. S., MAERZ, B., Lehrke, M., Singer, K., et al. (2026) · Cells · doi:10.3390/cells15050482
“However, plasma GLP-1 also increases in response to inflammatory stress such as with cytokine or lipopolysaccharide (LPS) administration [7–11] and after gut barrier injury, suggesting that L-cells respond not only to nutrients but also pathogen stimuli [12].”
Modulation of the immuno-metabolism axis in type-1 diabetes
Boubenna, N. (2010) · theses.fr (ABES) · doi:10.70675/2f05b49ez9e17z4db0zaa84z316c3f57dfd9
Adaptive changes of human islets to an obesogenic environment in the mouse
Gargani, S. (2013) · theses.fr (ABES) · doi:10.70675/cebf7176z1bb8z414bzb159ze850f327d2d5
Monchablon, M. (2023) · theses.fr (ABES) · doi:10.70675/1674d15ez05eaz4b9ezb932z6d4cd7d64426
関節リウマチ患者の糖化ヘモグロビンに対して腫瘍壊死因子阻害薬およびトシリズマブの与える影響;観察研究
Otsuka, Y. (2019) · Institutional Repositories DataBase (IRDB)
Lombardo, B., Ferro, S., Ferri, F., Callegari, C., Gerardi, G., Lutz, T. A., Hilbe, M., Kook, P. H., & Zini, E. (2026) · Veterinary Sciences · doi:10.3390/vetsci13111168
Metadata
- Authors
- Ellingsgaard, H., Ehses, J. A., Hammar, E. B., Van Lommel, L., Quintens, R., Martens, G., Kerr-Conte, J., Pattou, F., Berney, T., Pipeleers, D., Halban, P. A., Schuit, F. C., & Donath, M. Y.
- Affiliations
- University Hospital Zurich (CH)
- University of Geneva (CH)
- Gene Expression Unit, Department of Molecular Cell Biology, Katholieke Universiteit Leuven, 3000 Leuven, Belgium;
- KU Leuven (BE)
- Diabetes Research Center, Brussels Free University, Laarbeeklaan 103, B-1090 Brussels, Belgium; and
- Inserm (FR)
- **Cell Therapy of Diabetes, ERIT-M 0106, Institut National de la Santé et de la Recherche Médicale, Faculty of Medicine, 1 Place de Verdun, 59045 Lille, France
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-09-02
- Volume
- 105
- Issue
- 35
- Pages
- 13163-13168
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2529061
- OpenAlex
- W2032658955
- Cited by
- 269
- References
- 40
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 21 · 2023: 22 · 2022: 11 · 2021: 16 · 2020: 13 · 2019: 19 · 2018: 14 · 2017: 12 · 2016: 14 · 2015: 22 · 2014: 18 · 2013: 23 · 2012: 17
- FWCI
- 13.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- interleukin-6, alpha cells, IL-6 receptor, glucagon secretion, alpha-cell proliferation, high-fat diet, type 2 diabetes, beta-cell compensation, insulin secretion, obesity, islets
- MeSH terms
- Animals, Dietary Fats, Feeding Behavior, Gene Expression Regulation, Glucagon, Glucose Tolerance Test, Humans, Male, Mice, Inbred C57BL, Phosphorylation, Protein Precursors, RNA, Messenger, Interleukin-6, Rats, Wistar, Apoptosis, Mice, Knockout, Receptors, Interleukin-6, Cell Proliferation, Glucagon-Secreting Cells, Insulin-Secreting Cells, STAT3 Transcription Factor, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.